Global sales of surgical masks and respirators are projected to reach over $10 billion in 2020. This number represents a massive increase over historical data LSI has been reporting for the last decade.
HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)–#lsintelligence—Life Science Intelligence (LSI) has been tracking and publishing market data on the global surgical apparel market and protective personal equipment (PPE) market for the last decade. LSI’s new market report, Global Opportunities in Surgical Masks and Respirators Market – Impact Analysis of Coronavirus Outbreak provides a reliable and independent forecast of the COVID-19 impact to these markets.
According to the new report, global sales of surgical masks and respirators will exceed pre-pandemic estimates for these products by 211% and 305%, respectively. In 2020, global sales of surgical masks and respirators are projected to reach between $8.0 and $10.7 billion, depending on how the virus spreads. A massive increase in demand for these products, coupled with unit shortages, have caused average sale prices to increase by as much as 4X.
The report features three projected forecasts that take into consideration different scenarios of transmission and containment. These forecasts project revenue and units distributed assuming contained, sustained, and widespread transmission of the virus.
Companies covered in this analysis include: 3M (MMM), Cardinal Health (CAH), Honeywell International (HON), Premier, Prestige Ameritech, Alpha Pro Tech (APT), Makrite Industries, Moldex Metric, Aero Pro, Louis M. Gerson Company, Shanghai Dasheng Health Products, Foss Performance Materials, Hakugen Earth, and Shanghai Gangkai Purifying Products Company, among others.
More about this report and other medical device & diagnostic markets impacted by COVID-19 and the corresponding financial crisis can be found here: https://www.lifesciencemarketresearch.com/market-reports
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.
Contacts
Scott Pantel
Life Science Intelligence
714 847 3540 Tel
scott@LS-intel.com
ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…
ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…
In this free webinar, learn about the advantages of leveraging EPQT and AI-powered data quality…
In this free webinar, learn how to identify sources of variability in bioassay method transfers…
In this free webinar, learn how medical devices benefit from modern digital validation strategies. Attendees…
Backed by $14M in seed funding led by Andreessen Horowitz, and pre-seed funding led by…
